Literature DB >> 33658690

Hippo signalling maintains ER expression and ER+ breast cancer growth.

Shenghong Ma1,2, Zhengming Wu1,2, Feng Yang3, Jianmin Zhang4, Randy L Johnson5, Michael G Rosenfeld3, Kun-Liang Guan6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33658690      PMCID： PMC8725601          DOI： 10.1038/s41586-020-03131-5

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis.

Authors:  Xu Li; Shu Zhuo; Ting Zhuang; Jian Zhu; Yong Suk Cho; Guojin Wu; Yuchen Liu; Kun Mu; Kai Zhang; Peng Su; Yingzi Yang; Cheng Cheng Zhang; Jin Jiang
Journal:  Nat Commun       Date:  2022-06-02       Impact factor: 17.694

2.  RASSF1A-Mediated Suppression of Estrogen Receptor Alpha (ERα)-Driven Breast Cancer Cell Growth Depends on the Hippo-Kinases LATS1 and 2.

Authors:  Sven Roßwag; Jonathan P Sleeman; Sonja Thaler
Journal:  Cells       Date:  2021-10-24       Impact factor: 6.600

Review 3.  A narrative review for the Hippo-YAP pathway in cancer survival and immunity: the Yin-Yang dynamics.

Authors:  Ruochong Wang; Guiquan Zhu
Journal:  Transl Cancer Res       Date:  2022-01       Impact factor: 1.241

4.  Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer.

Authors:  Shenghong Ma; Tracy Tang; Gary Probst; Andrei Konradi; Chunyu Jin; Fulong Li; J Silvio Gutkind; Xiang-Dong Fu; Kun-Liang Guan
Journal:  Nat Commun       Date:  2022-02-25       Impact factor: 17.694

5.  YAP Dictates Mitochondrial Redox Homeostasis to Facilitate Obesity-Associated Breast Cancer Progression.

Authors:  Jia-Zih Dai; Yen-Ju Wang; Cheng-Hsun Chen; I-Lin Tsai; Yi-Chun Chao; Cheng-Wei Lin
Journal:  Adv Sci (Weinh)       Date:  2022-02-18       Impact factor: 17.521

Review 6.  Transcriptional Regulation of the Hippo Pathway: Current Understanding and Insights from Single-Cell Technologies.

Authors:  Sayantanee Paul; Shiqi Xie; Xiaosai Yao; Anwesha Dey
Journal:  Cells       Date:  2022-07-17       Impact factor: 7.666

7.  Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasis.

Authors:  Yujuan Jin; Qiqi Zhao; Weikang Zhu; Yan Feng; Tian Xiao; Peng Zhang; Liyan Jiang; Yingyong Hou; Chenchen Guo; Hsinyi Huang; Yabin Chen; Xinyuan Tong; Jiayu Cao; Fei Li; Xueliang Zhu; Jun Qin; Dong Gao; Xin-Yuan Liu; Hua Zhang; Luonan Chen; Roman K Thomas; Kwok-Kin Wong; Lei Zhang; Yong Wang; Liang Hu; Hongbin Ji
Journal:  Natl Sci Rev       Date:  2022-01-04       Impact factor: 23.178

8.  ARSD, a novel ERα downstream target gene, inhibits proliferation and migration of breast cancer cells via activating Hippo/YAP pathway.

Authors:  Yun Lin; Chun Li; Wei Xiong; Liping Fan; Hongchao Pan; Yaochen Li
Journal:  Cell Death Dis       Date:  2021-11-02       Impact factor: 8.469
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.